Ming He

ORCID: 0000-0002-1007-3583 · 11 papers in corpus · active 2013-2026

Study types

  • article 8
  • other 3

Condition tags

  • endometriosis 6
  • mesh:D004715 3
  • infertility 1
  • adenomyosis 1
article 2026
·doi:10.1186/s40001-026-04545-z

Endometriosis is a prevalent gynecological disorder characterized by the ectopic growth of endometrial-like tissue, often leading to chronic pelvic pain, infertility, and reduced quality of life. Despite available treatments, therapeutic ou…

other 2026
Journal of ethnopharmacology ·doi:10.1016/j.jep.2026.121392

ETHNOPHARMACOLOGICAL RELEVANCE: Endometriosis (EMs) is a prevalent and challenging gynecological disease and current therapeutic outcomes are suboptimal. Traditional Chinese medicine (TCM) has numerous advantages in treating EMs. Bushen Wen…

article 2022
·doi:10.1016/j.jep.2022.115777
article 2022
Reproduction, fertility, and development ·doi:10.1071/rd22020

CONTEXT: N -acetyl-cysteine (NAC) is a potent antioxidant that can be used for many gynecological diseases such as polycystic ovary syndrome and endometriosis. Controlled ovarian hyperstimulation (COH) is a critical step in infertility trea…

article 2021
·doi:10.1016/j.jep.2021.114580
other 2020
Journal of cellular biochemistry ·doi:10.1002/jcb.29406

MiR-145 has been shown to suppress cell invasiveness and proliferation in endometriosis, whereas prostate cancer-associated transcript 1 (PCAT1) was reported to act as a sponge of miR-145 with one single-nucleotide polymorphism (SNP), rs710…

article 2018
Mutation research ·doi:10.1016/j.mrfmmm.2018.12.003
article 2016
Gene ·doi:10.1016/j.gene.2016.12.011
article 2015
·doi:10.1039/c5ay01312g

A high throughput metabolite fingerprinting tool based on WT-ESI-MS has been established for the serum metabolic profiling study of endometriosis with little sample pre-treatment, no chromatography and instrument cycle times of less than 5 …

article 2014
Mutation research ·doi:10.1016/j.mrfmmm.2014.01.003
other 2013
Molecular medicine reports ·doi:10.3892/mmr.2013.1416

Protein phosphatase 2, regulatory subunit A, α (PPP2R1A) and β (PPP2R1B) are paralogous subunits of the heterotrimeric protein phosphatase 2 (PP2A) holoenzyme that catalyzes the dephosphorylation of target substrate proteins. Subtype‑specif…